Evidence map›Paper›PMID 34183705›Full record

ArticleScientific reports2021

Follow-up of COVID-19 recovered patients with mild disease.

Alina Kashif, Manahil Chaudhry, Tehreem Fayyaz, Mohammad Abdullah, Ayesha Malik, Javairia Manal Akmal Anwer, Syed Hashim Ali Inam, Tehreem Fatima, Noreena Iqbal, Khadija Shoaib

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  14. Systematic Review of the Prevalence of Long COVID.Open forum infectious diseases · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Perceived Consequences of Post-COVID-19 and Factors Associated with Low Life Satisfaction.International journal of environmental research and public health · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alina KashifMedicine, CMH Lahore Medical College & Institute of Dentistry, Lahore, Pakistan.
Manahil ChaudhryMedicine, Hameed Latif Hospital, Lahore, Pakistan.
Tehreem FayyazMedicine, CMH Lahore Medical College & Institute of Dentistry, Lahore, Pakistan.
Mohammad AbdullahMedicine, CMH Lahore Medical College & Institute of Dentistry, Lahore, Pakistan. mohammadabdullah_786@hotmail.com.
Ayesha MalikMedicine, Hameed Latif Hospital, Lahore, Pakistan.
Javairia Manal Akmal AnwerMedicine, CMH Lahore Medical College & Institute of Dentistry, Lahore, Pakistan.
Syed Hashim Ali InamMedicine, CMH Lahore Medical College & Institute of Dentistry, Lahore, Pakistan.
Tehreem FatimaMedicine, Hameed Latif Hospital, Lahore, Pakistan.
Noreena IqbalMedicine, Milton Keynes University Hospital, Milton Keynes, UK.
Khadija ShoaibMedicine, CMH Lahore Medical College & Institute of Dentistry, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of the 11 studied symptoms were notably more prevalent amongst the female sample population. Our results validate the presence of prolonged symptoms months after recovery from mild COVID-19 disease, particularly in association with the female gender. Hence, proving the post-COVID syndrome is a recognizable diagnosis in the bigger context of the post-viral fatigue syndrome.

Indexed as

AdultComorbidityCOVID-19FatigueFemaleFollow-Up StudiesHumansMaleMiddle AgedPost-Acute COVID-19 SyndromeSARS-CoV-2Severity of Illness IndexSex FactorsYoung Adult

Identifiers

PMID34183705
PMCPMC8239036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.